Literature DB >> 9032939

Synergistic antitumour activity of vitamins C and K3 against human prostate carcinoma cell lines.

M Venugopal1, J M Jamison, J Gilloteaux, J A Koch, M Summers, J Hoke, C Sowick, J L Summers.   

Abstract

Vitamins C, K3 (VC, VK3) and a VC/VK3 combination with a VC:VK3 ratio of 100:1 were assayed for their antitumour activity against two human prostatic carcinoma cell lines. Co-administration of the vitamins enhanced the antitumour activity 5- to 20-fold even with a 1 h exposure time. While exogenous catalase destroyed the antitumour activity, hydrogen peroxide-induced lipid peroxidation was negligible. Analysis of cellular ATP and thiol levels as well as DNA and protein synthesis revealed: a transient increase in ATP production, a decrease in DNA synthesis, an increase in protein synthesis and a decrease in thiol levels. These results suggested that the increased cytotoxicity of the vitamin combination was due to redox cycling and increased oxidative stress.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9032939     DOI: 10.1006/cbir.1996.0102

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  7 in total

1.  Nucleolar changes and fibrillarin redistribution following apatone treatment of human bladder carcinoma cells.

Authors:  James M Jamison; Jacques Gilloteaux; Laszlo Perlaky; Marc Thiry; Karel Smetana; Deborah Neal; Karen McGuire; Jack L Summers
Journal:  J Histochem Cytochem       Date:  2010-04-12       Impact factor: 2.479

2.  Serum markers variation consistent with autoschizis induced by ascorbic acid-menadione in patients with prostate cancer.

Authors:  Eduardo Lasalvia-Prisco; Silvia Cucchi; Jesús Vázquez; Eduardo Lasalvia-Galante; Wilson Golomar; William Gordon
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

Review 3.  Roles of autophagy induced by natural compounds in prostate cancer.

Authors:  V Naponelli; A Modernelli; S Bettuzzi; F Rizzi
Journal:  Biomed Res Int       Date:  2015-03-03       Impact factor: 3.411

4.  Selective Targeting of Cancerous Mitochondria and Suppression of Tumor Growth Using Redox-Active Treatment Adjuvant.

Authors:  Rumiana Bakalova; Severina Semkova; Donika Ivanova; Zhivko Zhelev; Thomas Miller; Tsuguhide Takeshima; Sayaka Shibata; Dessislava Lazarova; Ichio Aoki; Tatsuya Higashi
Journal:  Oxid Med Cell Longev       Date:  2020-11-02       Impact factor: 6.543

Review 5.  High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer.

Authors:  Franziska Böttger; Andrea Vallés-Martí; Loraine Cahn; Connie R Jimenez
Journal:  J Exp Clin Cancer Res       Date:  2021-10-30

6.  The Combination of Vitamin K3 and Vitamin C Has Synergic Activity against Forms of Trypanosoma cruzi through a Redox Imbalance Process.

Authors:  Vânia Cristina Desoti; Danielle Lazarin-Bidóia; Fabianne Martins Ribeiro; Solange Cardoso Martins; Jean Henrique da Silva Rodrigues; Tania Ueda-Nakamura; Celso Vataru Nakamura; Valdecir Farias Ximenes; Sueli de Oliveira Silva
Journal:  PLoS One       Date:  2015-12-07       Impact factor: 3.240

7.  2-Bromo-1,4-naphthoquinone: a potentially improved substitute of menadione in Apatone™ therapy.

Authors:  F S Graciani; V F Ximenes
Journal:  Braz J Med Biol Res       Date:  2012-05-17       Impact factor: 2.590

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.